Real-World Cohort Study of Cardiopulmonary Function in Chinese Patients With Cardiovascular Disea… (NCT07130968) | Clinical Trial Compass
By InvitationNot Applicable
Real-World Cohort Study of Cardiopulmonary Function in Chinese Patients With Cardiovascular Disease: CPET Evaluation and Five-Year Prognostic Follow-Up Based on a Multicenter Structured Data Platform
China200,000 participantsStarted 2025-02-01
Plain-language summary
The goal of this observational study is to observe the characteristics of cardiopulmonary exercise testing (CPET) parameters in patients across different cardiovascular diseases and to evaluate the predictive value of multiparameter cardiopulmonary indices for 5-year major adverse cardiovascular events (MACE).
Who can participate
Age range
18 Years – 80 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
. Age: 18-80 years,
. Ability to comprehend and provide written informed consent.
Exclusion criteria
. Comorbid severe conditions (e.g., recent acute myocardial infarction, unstable angina, uncontrolled arrhythmias, severe aortic coarctation or descending aortic aneurysm, acute myocarditis or pericarditis, acute congestive heart failure, acute respiratory failure, resting oxygen saturation \<93%, recent arterial or pulmonary embolism, pulmonary edema).
. Physical disability due to musculoskeletal or neuromuscular disorders.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This study is 'enrolling by invitation only' — could you tell me whether I might be eligible to be invited, and what criteria they're using to select participants?
2Since this is an observational cohort study rather than a treatment trial, does taking part in it change anything about the care or medications I'd receive, or does it simply involve monitoring and testing like the cardiopulmonary exercise test (CPET)?
3The study plans to follow participants for five years and track serious events like heart attack, stroke, and cardiac death — what does that level of follow-up commitment actually involve for me in terms of clinic visits or check-ins?
4I see the study uses something called CPET to evaluate cardiopulmonary function — is that a safe test given my specific cardiovascular condition, and are there any risks I should understand before agreeing to it?
5Given that this is a real-world data and observation study rather than a trial testing a new treatment, how does joining it compare to simply staying on my current treatment plan — is there any direct benefit to me, or is it primarily contributing to research?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Characteristics of CPET parameters across different cardiovascular diseases.
Timeframe: After enrollment
2
Incidence of 5-year MACE
Timeframe: from enrollment to 5 years post-enrollment